CCDR: Volume 50-1/2, January/February 2024: Respiratory Syncytial Virus (RSV)

Table of contents

Overview

Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and people
EM Abrams, P Doyon-Plourde, P Davis, N Brousseau, A Irwin, W Siu, A Killikelly

Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021–2022
E Giang, Y Xu, T Naganathan, N Abraham, M-T Bawolak, B Said Salim, A Weeks, A Shaw, S Ogunnaike-Cooke

Scoping Review

Disease burden attributable to respiratory syncytial virus outbreaks in long-term care
C Ferrante, C Bancej, N Atchessi

Commentary

PCV13, PCV15 or PCV20: Which vaccine is best for children in terms of immunogenicity?
P De Wals

Surveillance

COVID-19 outcome trends by vaccination status in Canada, December 2020–January 2022
D Dam, S Merali, M Chen, C Coulby, B Ho Mi Fane, F Bang, J Robson, S David

National safety monitoring of vaccines from the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), 2018–2019
M El Jaouhari, K Johnson, H Anyoti, Y Xu, C Wells, A Weeks, A Yeung, A Shaw, S Ogunnaike-Cooke

Wastewater surveillance for COVID-19 in shelters: A creative strategy for a complex setting
C Ranasinghe, S Baral, R Stuart, C Oswald, S Straus, A Tehrani, K Gilbride, P Agyemang, A Orkin

Epidemiologic Study

Evolution of illness severity in hospital admissions due to COVID-19, Québec, Canada, January to April 2022
E Lo, É Fortin, R Gilca, P-L Trépanier, H Geagea, Z Zhou

Epidemiological characteristics of human infections with avian influenza A(H5N6) virus, China and Laos: A multiple case descriptive analysis, February 2014–June 2023
S Sandhu, C Ferrante, A MacCosham, N Atchessi, C Bancej